Domenica Altavilla

Domenica Altavilla

Auto-generated profile, based on publicly available information

Domenica Altavilla

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
NINatasha Irrera
Natasha Irrera
MCMariapaola Cucinotta
Mariapaola Cucinotta
Giovanni PallioGiovanni Pallio
Giovanni Pallio
FMFederica Mannino
Federica Mannino
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Oxidative stress is a phenomenon caused by an imbalance between production and accumulation of oxygen reactive species (ROS) in cells and tissues and the ability of a biological system to detoxify these reactive products. ROS can play, and in fact they do it, several physiological roles (i.e., cell signaling), and they are normally generated as by‐products of oxygen metabolism; despite this, environmental stressors (i.e., UV, ionizing radiations, pollutants, and heavy metals) and xenobiotics (i.e., antiblastic drugs) contribute to greatly increase ROS production, therefore causing the imbalance that leads to cell and tissue damage (oxidative stress). Several antioxidants have been exploited in recent years for their actual or supposed beneficial effect against oxidative stress, such as vitamin E, flavonoids, and polyphenols. While we tend to describe oxidative stress just as harmful for human body, it is true as well that it is exploited as a therapeutic approach to treat clinical conditions such as cancer, with a certain degree of clinical success. In this review, we will describe the most recent findings in the oxidative stress field, highlighting both its bad and good sides for human health.

1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
NINatasha Irrera
Natasha Irrera
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Giovanni PallioGiovanni Pallio
Giovanni Pallio
FMFederica Mannino
Federica Mannino
DADomenica Altavilla
Domenica Altavilla
Experimental evidence suggests that cadmium (Cd) boosts oxidative stress that may result in toxicity on the endocrine system also in humans. The aim of this study was to investigate the glycemic control and oxidative stress markers in male adolescents with increased urinary levels of cadmium. We investigated 111 males, aged 12–14 years, living in a polluted area of Sicily and a control age‐matched population (n = 60) living 28–45 km far from the polluted site. Malondialdehyde (MDA), total antioxidant activity (TAC), metallothionein‐1A (MT‐1A) gene expression, insulin resistance by the homeostatic model assessment (HOMA‐IR), and urinary cadmium were investigated. Cd levels were significantly higher in adolescents living in the polluted area than in control age‐matched subjects. Adolescents with elevated Cd levels had a significant increase in MDA, MT‐1A, and HOMA‐IR and reduced TAC compared to the control group. A robust correlation was found between urinary cadmium and MT‐1A, HOMA‐IR, and MDA whereas an inverse correlation was identified between urinary cadmium and TAC. This study indicates that cadmium burden alters glycemic control in adolescents and suggests that oxidative stress plays a key role in cadmium‐induced insulin resistance, increasing the risk of developing metabolic disorders.

24 August 2014 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
Alessandra BittoAlessandra Bitto
Alessandra Bitto
FSFrancesco Squadrito
Francesco Squadrito
NINatasha Irrera
Natasha Irrera
GPGabriele Pizzino
Gabriele Pizzino
Giovanni PallioGiovanni Pallio
Giovanni Pallio
DADomenica Altavilla
Domenica Altavilla
Flavonoids, fromScutellaria baicalensis(Chinese skullcap) andAcacia catechu(black catechu), have been shown to exert a variety of therapeutic effects, including anti-inflammatory, antiviral, antibacterial, and anticancer activities. Flavocoxid is a mixed extract containing baicalin and catechin and it acts as a dual balanced inhibitor of cyclooxygenase-1 (COX-1) and COX-2 peroxidase enzyme activities with a significant inhibition of 5-lipoxygenase (5-LOX) enzyme activityin vitro. Flavocoxid downregulates gene or protein expression of several inflammatory markers and exerts also strong antioxidant activity in several experimental models. Controlled clinical trials and a postmarketing study have clearly shown that flavocoxid is as effective as naproxen in managing the signs and symptoms of osteoarthritis of the knee and it has better upper gastrointestinal, renal, and respiratory safety profile than naproxen. Flavocoxid may therefore provide a potential therapeutic approach to the treatment of chronic inflammatory conditions.

1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
GPGabriele Pizzino
Gabriele Pizzino
Alessandra BittoAlessandra Bitto
Alessandra Bitto
Giovanni PallioGiovanni Pallio
Giovanni Pallio
NINatasha Irrera
Natasha Irrera
FGFederica Galfo
Federica Galfo
DADomenica Altavilla
Domenica Altavilla
Cecal ligation and puncture (CLP) is an experimental polymicrobial sepsis induced systemic inflammation that leads to acute organ failure. Aim of our study was to evaluate the effects of SP600125, a specific c‐Jun NH2‐terminal kinase (JNK) inhibitor, to modulate the early and late steps of the inflammatory cascade in a murine model of CLP‐induced sepsis. CB57BL/6J mice were subjected to CLP or sham operation. Animals were randomized to receive either SP600125 (15 mg/kg) or its vehicle intraperitoneally 1 hour after surgery and repeat treatment every 24 hours. To evaluate survival, a group of animals was monitored every 24 hours for 120 hours. Two other animals were sacrificed 4 or 18 hours after surgical procedures; lung and liver samples were collected for biomolecular and histopathologic analysis. The expression of p‐JNK, p‐ERK, TNF‐α, HMGB‐1, NF‐κB, Ras, Rho, Caspase 3, Bcl‐2, and Bax was evaluated in lung and liver samples; SP600125 improved survival, reduced CLP induced activation of JNK, NF‐κB, TNF‐α, and HMGB‐1, inhibited proapoptotic pathway, preserved Bcl‐2 expression, and reduced histologic damage in both lung and liver of septic mice. SP600125 protects against CLP induced sepsis by blocking JNK signalling; therefore, it can be considered a therapeutic approach in human sepsis.

1 January 2018 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
AMAntonio Micali
Antonio Micali
Giovanni PallioGiovanni Pallio
Giovanni Pallio
NINatasha Irrera
Natasha Irrera
Herbert Ryan MariniHerbert Ryan Marini
Herbert Ryan Marini
VTVincenzo Trichilo
Vincenzo Trichilo
LMLetteria Minutoli
Letteria Minutoli
Background. Cadmium (Cd), a diffused environmental pollutant, has adverse effects on urinary apparatus. The role of flavocoxid, a natural flavonoid with antioxidant activity, on the morphological and biochemical changes induced in vivo by Cd in mice kidney was evaluated. Methods. C57 BL/6J mice received 0.9% NaCl alone, flavocoxid (20 mg/kg/day i.p.) alone, Cd chloride (CdCl2) (2 mg/kg/day i.p.) alone, or CdCl2 plus flavocoxid (2 mg/kg/day i.p. plus 20 mg/kg/day i.p.) for 14 days. The kidneys were processed for biochemical, structural, ultrastructural, and morphometric evaluation. Results. Cd treatment alone significantly increased urea nitrogen and creatinine, iNOS, MMP‐9, and pERK 1/2 expression and protein carbonyl; reduced GSH, GR, and GPx; and induced structural and ultrastructural changes in the glomeruli and in the tubular epithelium. After 14 days of treatment, flavocoxid administration reduced urea nitrogen and creatinine, iNOS, MMP‐9, and pERK 1/2 expression and protein carbonyl; increased GSH, GR, and GPx; and showed an evident preservation of the glomerular and tubular structure and ultrastructure. Conclusions. A protective role of flavocoxid against Cd‐induced oxidative damages in mouse kidney was demonstrated for the first time. Flavocoxid may have a promising antioxidant role against environmental Cd harmful effects on glomerular and tubular lesions.

30 April 2009 in Journal of Urology
Verified
Journal Article
Closed access
LMLetteria Minutoli
Letteria Minutoli
PAPietro Antonuccio
Pietro Antonuccio
FPFrancesca Polito
Francesca Polito
ABAlessandra Bitto
Alessandra Bitto
FSFrancesco Squadrito
Francesco Squadrito
DADomenica Altavilla
Domenica Altavilla
Purpose: Testicular torsion is a medical emergency that requires immediate diagnosis and treatment to avoid subsequent testicular injury and infertility. PPARs are a family of nuclear hormone receptors belonging to the steroid receptor superfamily. Three PPAR isotypes (α, β/δ and γ) encoded by separate genes and showing different tissue distribution patterns have been identified. PPARβ/δ is expressed in testis and its role is largely unknown. We tested whether pharmacological activation of PPARβ/δ might protect the testis from ischemia and reperfusion injury. Materials and Methods: Adult male Sprague-Dawley rats were subjected to 1-hour testicular ischemia, followed by 24 hours of reperfusion. Sham testicular ischemia-reperfusion rats served as controls. The animals were randomized to receive immediately after detorsion 1) L-165,041 (4 mg/kg intraperitoneally), a potent agonist of PPARβ/δ, 2) GW9662 (Calbiochem®) (4 mg/kg intraperitoneally), an antagonist of PPAR, 3) L-165,041 (4 mg/kg intraperitoneally) plus GW9662 (4 mg/kg intraperitoneally) concomitantly or 4) vehicle (1 ml/kg 10% dimethyl sulfoxide/NaCl solution). We evaluated testicular extracellular signal regulated kinase, tumor necrosis factor-α and interleukin-6 by Western blot. We also investigated PPARβ/δ activation by Western blot, mRNA expression and organ damage. Results: Testicular ischemia-reperfusion injury caused a significant increase in extracellular signal regulated kinase, tumor necrosis factor-α and interleukin-6 expression in each testis. Furthermore, histological examination revealed marked damage. L-165,041 administration increased the PPARβ/δ message and protein, inhibited extracellular signal regulated kinase, tumor necrosis factor-α and interleukin-6 expression, and decreased histological damage. Concomitant administration of GW9662 reversed the protection exerted by PPARβ/δ agonist. Conclusions: These findings indicate that PPARβ/δ agonists might be an attractive therapeutic candidate for managing testicular torsion.